Patent details

Basic Information

Publication number:

EP2586443

PCT Application Number:

PCT/JP/2011/064430

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP117982249

PCT Publication Number:

WO/2011/162343

First applicant's nationality:

Translation Language:

EPO Publication Language:

Not available

English Title of Invention:

ANTITUMOR AGENT USING COMPOUNDS HAVING KINASE INHIBITORY EFFECT IN COMBINATION

French Title of Invention:

AGENT ANTICANCÉREUX UTILISANT DES COMPOSÉS AYANT UN EFFET INHIBITEUR DE KINASE EN COMBINAISON

German Title of Invention:

ANTITUMORWIRKSTOFF MIT VERBINDUNGEN MIT KINASEHEMMUNGSWIRKUNG IN KOMBINATION

SPC Number:

Dates

Filing date:

23/06/2011

Grant date:

16/03/2016

EP Publication Date:

16/03/2016

PCT Publication Date:

29/12/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/05/2013

EP B1 Publication Date:

16/03/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

23/06/2016

Expiration date:

23/06/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/06/2011

 

 

Name:

Eisai R&D Management Co. Ltd.

Address:

6-10, Koishikawa 4-chome Bunkyo-ku, Tokyo 112-8088, Japan (JP)

Inventor

1

Name:

NAKAGAWA Takayuki

Address:

Japan (JP)

2

Name:

MATSUSHIMA Tomohiro

Address:

Japan (JP)

3

Name:

FUNAHASHI Yasuhiro

Address:

United States (US)

Priority

1

Priority Number:

2010145030

Priority Date:

25/06/2010

Priority Country:

Japan (JP)

2

Priority Number:

2010273921

Priority Date:

08/12/2010

Priority Country:

Japan (JP)

Classification

Main IPC Class:

A61K 31/47;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages